Israel’s Sheba Medical Center is partnering with Thomas Jefferson University in the USA, to promote neuroscience research and clinical treatment at both institutions. It includes construction of a cutting-edge neuroscience center on Sheba’s Tel HaShomer campus, targeted to open in … Continue reading →

A recent clinical study has shown that AstaPure Arava® by Israel’s Solabia- Algatech Nutrition benefits the immune system and lowers stress. It boosts the gut microbiome while lowering the stress hormone cortisol. The result is a much better resistance to … Continue reading →

Israel’s Genetika+ is developing a precision tool to determine if a particular antidepressant will work for an individual. It will also apparently highlight any side effects. (See also Taliaz.) https://nocamels.com/2022/09/brain-in-a-dish-tech-antidepressant/ https://www.genetikaplus.com/ https://www.youtube.com/watch?v=7oovQR2j1M8

Ofer Shalev, Founder & CEO at Israel’s New Phase (see here previously) spoke at CTech’s Mind the Tech NY Conference.  New Phase’s hyperthermic therapy reduces cancer from Stage 4 to Stage 2 so patients can live with a better quality … Continue reading →

Professors from the Hebrew University of Jerusalem and the Hadassah Cancer Research Institute are leading CanceRNA – a European consortium working to develop novel immunotherapy treatments for cancer. The consortium will initially focus on treating acute myeloid leukemia. https://www.jns.org/israelis-lead-intl-hunt-for-innovative-cancer-treatments/